These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24218178)

  • 1. Inhibiting and reversing amyloid-β peptide (1-40) fibril formation with gramicidin S and engineered analogues.
    Luo J; Otero JM; Yu CH; Wärmländer SK; Gräslund A; Overhand M; Abrahams JP
    Chemistry; 2013 Dec; 19(51):17338-48. PubMed ID: 24218178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of aggregation of amyloid peptides by beta-sheet breaker peptides and their binding affinity.
    Viet MH; Ngo ST; Lam NS; Li MS
    J Phys Chem B; 2011 Jun; 115(22):7433-46. PubMed ID: 21563780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
    Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the efficiency and interaction mechanism of a decapeptide inhibitor of β-amyloid aggregation.
    Liu J; Wang W; Zhang Q; Zhang S; Yuan Z
    Biomacromolecules; 2014 Mar; 15(3):931-9. PubMed ID: 24443821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide.
    Sheikh AM; Nagai A
    FEBS J; 2011 Feb; 278(4):634-42. PubMed ID: 21205198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Aβ(1-40) peptide fibrillar architectures by Aβ-based peptide amphiphiles.
    He C; Han Y; Zhu L; Deng M; Wang Y
    J Phys Chem B; 2013 Sep; 117(36):10475-83. PubMed ID: 23957218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
    Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
    Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?
    Bieschke J; Siegel SJ; Fu Y; Kelly JW
    Biochemistry; 2008 Jan; 47(1):50-9. PubMed ID: 18078350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro amyloid-β binding and inhibition of amyloid-β self-association by therapeutic albumin.
    Milojevic J; Costa M; Ortiz AM; Jorquera JI; Melacini G
    J Alzheimers Dis; 2014; 38(4):753-65. PubMed ID: 24072068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of β-sheet ligands against Aβ42-induced toxicity.
    Hochdörffer K; März-Berberich J; Nagel-Steger L; Epple M; Meyer-Zaika W; Horn AH; Sticht H; Sinha S; Bitan G; Schrader T
    J Am Chem Soc; 2011 Mar; 133(12):4348-58. PubMed ID: 21381732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
    Singh PK; Maji SK
    Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
    Marsh DT; Das S; Ridell J; Smid SD
    Bioorg Med Chem; 2017 Jul; 25(14):3827-3834. PubMed ID: 28559058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Alzheimer's Biomarker FDDNP Binding to Aβ Amyloid Fibril.
    Parikh ND; Klimov DK
    J Phys Chem B; 2015 Sep; 119(35):11568-80. PubMed ID: 26237080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology.
    Bett CK; Ngunjiri JN; Serem WK; Fontenot KR; Hammer RP; McCarley RL; Garno JC
    ACS Chem Neurosci; 2010 Sep; 1(9):608-26. PubMed ID: 22778850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
    Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
    Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of the neurotoxic membrane actions of amyloid-β on hippocampal neurons in Alzheimer's disease.
    Sepúlveda FJ; Fierro H; Fernandez E; Castillo C; Peoples RW; Opazo C; Aguayo LG
    Neurobiol Aging; 2014 Mar; 35(3):472-81. PubMed ID: 24112789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.
    Chimon S; Shaibat MA; Jones CR; Calero DC; Aizezi B; Ishii Y
    Nat Struct Mol Biol; 2007 Dec; 14(12):1157-64. PubMed ID: 18059284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted tryptophans at amyloid-β(1-40) residues 19 and 20 experience different environments after fibril formation.
    McDonough RT; Paranjape G; Gallazzi F; Nichols MR
    Arch Biochem Biophys; 2011 Oct; 514(1-2):27-32. PubMed ID: 21843498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A carboxylated Zn-phthalocyanine inhibits fibril formation of Alzheimer's amyloid β peptide.
    Tabassum S; Sheikh AM; Yano S; Ikeue T; Handa M; Nagai A
    FEBS J; 2015 Feb; 282(3):463-76. PubMed ID: 25404240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.